As detailed below, the potential return-on-investment results are:
- Pfizer Inc.: (1) +1.6% absolute
return in 13 days (equivalent to a +43.8% annualized
return-on-investment) if there is an early assignment on the day prior to the January 27th ex-dividend date; and (2) +2.3% absolute
return in 22 days (equivalent to a +38.6% annualized
return-on-investment) if the position is in-the-money and therefore assigned on the Feb. 4th options expiration date.
- iShares China Large-Cap ETF: +1.1% absolute return in 16 days (equivalent to a +24.8% annualized return-on-investment) if this Covered Calls position is assigned on its January 28th, 2022 options expiration date.
1.
Pfizer Inc. (PFE) -- New Covered Calls Position
01/14/2022 Bought 300 Pfizer shares @ $54.82
01/14/2022 Sold 3 Pfizer 02/04/2022 $53.00 Call options @ $2.64 Note: the Implied Volatility of the Calls was 30.7 and the Delta was 67.7 when this transaction was executed.
01/27/2022 Upcoming quarterly ex-dividend of $.40 per share
Two possible overall performance results (including commissions) for this Pfizer Inc. Covered Calls position are as follows:
Covered Calls Cost Basis: $15,656.01
= ($54.82 - $2.64) * 300 shares + $2.01 commission
Net Profit Components:
(a) Options Income: +$789.99
= ($2.64 * 300 shares) - $2.01 commission
(b) Dividend Income (If options exercised early on Jan. 26th, 2022 -- the business day prior to the Jan. 27th ex-div date): +$0.00; or
(b) Dividend Income (If Pfizer stock assigned at Feb. 4th, 2022 expiration): +$120.00
= ($.40 dividend per share x 300 shares)
(c) Capital Appreciation (If Pfizer Call options assigned early on Jan. 27th): -$546.00
+($53.00 - $54.82) * 300 shares; or
(c) Capital Appreciation (If shares assigned at $53.00 strike price at options expiration): -$546.00
+($53.00 - $54.82) * 300 shares
+($53.00 - $54.82) * 300 shares; or
(c) Capital Appreciation (If shares assigned at $53.00 strike price at options expiration): -$546.00
+($53.00 - $54.82) * 300 shares
1. Total Net Profit (If options exercised on business day prior to Jan. 27th ex-dividend date): +$243.99
= (+$789.99 options income +$0.00 dividend income -$546.00 capital appreciation); or
2. Total Net Profit (If Pfizer shares assigned at $53.00 strike price on February 4th, 2022 options expiration date): +$363.99
= (+$789.99 +$120.00 -$546.00)
1. Absolute Return (If options exercised early on January 26th, 2022): +1.6%
= +$243.99/$15,656.01
Annualized Return (If options exercised early): +43.8%
= (+$243.99/$15,656.01)*(365/13 days); or
2. Absolute Return (If Pfizer shares assigned at $53.00 at Feb. 4th, 2022 options expiration): +2.3%
= +$363.99/$15,656.01
Annualized Return (If Pfizer shares assigned at $53.00 on Feb. 4th, 2022 expiration): +38.6%
= (+$363.99/$15,656.01)*(365/22 days)
Either outcome provides a satisfactory return-on-investment result for this Pfizer investment. These returns will be achieved as long as the stock is above the $53.00 strike price at assignment. If the stock declines below the strike price, the breakeven price of $51.78 ($54.82 - $2.64 - $.40) provides 5.5% downside protection below today's stock purchase price.
2. iShares China Large-Cap ETF (FXI) -- New Covered Calls Position
The Buy/Write transaction was as follows:
01/13/2022 Bought 500 shares of iShares China Large-Cap ETF shares @ $37.76
01/13/2022 Sold 5 FXI January 28th, 2022 $36.50 Call options @ $1.66 per share. The Implied Volatility of the Calls was 28.3 and the Delta was 74.1 when this Covered Calls position was established.
A possible overall performance result (including commissions) for this iShares China Large-Cap ETF Covered Calls position is as follows:
Stock Purchase Cost: $18,053.35
= ($37.76 - $1.66) * 500 shares + $3.35 commission
Net Profit:
(a) Options Income: +$826.65
= ($1.66 * 500 shares) - $3.35 commission
(b) Dividend Income: +$0.00
Total Net Profit (If 500 iShares China Large-Cap ETF shares assigned at $36.50 strike price at expiration): +$196.65
Absolute Return-on-Investment: +1.1%
Stock Purchase Cost: $18,053.35
= ($37.76 - $1.66) * 500 shares + $3.35 commission
Net Profit:
(a) Options Income: +$826.65
= ($1.66 * 500 shares) - $3.35 commission
(b) Dividend Income: +$0.00
(c) Capital Appreciation (If 500 iShares China Large-Cap ETF shares assigned at $36.50 strike price at expiration): -$630.00
= +($36.50 - $37.76) * 500 shares
= +($36.50 - $37.76) * 500 shares
Total Net Profit (If 500 iShares China Large-Cap ETF shares assigned at $36.50 strike price at expiration): +$196.65
= (+$826.65 options income +$0.00 dividend income -$630.00 capital appreciation)
= +$196.65/$18,053.35
Annualized Return-on-Investment: +24.8%
= (+$196.65/$18,053.35) * (365/16 days)